SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending after its Q4 earnings report, which, despite solid subscriber growth and ad revenue, prompted a significant stock decline due to conservative Q1 guidance and investor concerns over the proposed Warner Bros. Discovery acquisition. The community is sharply divided; bulls view the deep pullback as an oversold opportunity given strong long-term fundamentals and content potential, while bears focus on the acquisition's cost, debt implications, and paused share buybacks as potential headwinds for future profitability.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is currently trending following a significant 10-year data center lease agreement with Riot Platforms, providing 25 megawatts of capacity with options for substantial expansion, signaling AMD's growing role in AI infrastructure. The community is highly optimistic, noting AMD's consistent strength even on broader market downturns and anticipating continued market share gains amidst surging demand for AI compute.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed Inc. is surging due to its subsidiary, Lucid Diagnostics, securing a significant contract with the U.S. Department of Veterans Affairs for its EsoGuard esophageal DNA test. This news has ignited intense discussion among traders, who are actively debating the potential for continued upside driven by its low float and the strategic importance of expanding esophageal cancer screening across the VA healthcare system, though some express skepticism given the company's past volatility.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is a hot topic amidst a sharp divergence of investor sentiment, primarily driven by its ambitious AI infrastructure expansion and substantial debt. While some highlight its impressive cloud backlog and potential for major AI contracts, others are concerned about increased capital expenditures, recent revenue performance, and a bondholder lawsuit related to debt financing, leading to fervent debate about its future trajectory.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid is a major discussion point after announcing it met revised 2025 production targets and increased vehicle deliveries, boosted by the Gravity SUV, alongside news of a robotaxi alliance with Uber and Nuro. While some investors see this as a sign of operational progress, community sentiment remains divided, with concerns over long-term profitability, cash burn, and leadership driving ongoing, intense debate within the challenging EV market.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending prominently amidst a flurry of community discussion ignited by its namesake's recent public statements, impacting market sentiment and international relations. A significant short interest is fueling debate among investors, with many anticipating a potential squeeze, while others raise concerns about the company's fundamentals and the ongoing political discourse.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a significant surge, driven by widespread anticipation surrounding its impending earnings report and recent analyst upgrades. The community is actively discussing the potential for a substantial short squeeze and a sustained upward trajectory, fueled by confidence in its manufacturing advancements and increasing AI server demand. While many foresee a strong breakout, others remain watchful for a 'sell the news' reaction after its impressive run.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following a non-exclusive licensing agreement with Pfizer for its Matrix-M adjuvant, a deal many view as significant validation for its platform technology. This partnership, involving an upfront payment and potential milestones, is driving discussions about future collaborations and the possibility of a short squeeze due to high short interest. However, some community members are questioning the upfront value and management's approach to capital allocation amidst ongoing calls for stronger shareholder-focused actions.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares are trending lower following a recent analyst report citing softer ad agency feedback, which has sparked a rapid decline and fueled discussions around potential insider selling. Despite this, other analysts remain bullish on its growth prospects from AI data licensing and ad product innovation, leading to community debate on whether the current volatility presents a buying opportunity ahead of upcoming earnings or signals deeper concerns for the social media platform.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining (HYMC) is trending due to recent high-grade silver drill results and a surge in precious metals prices, fueling speculation about its vast undeveloped resources. The community is sharply divided between those citing billionaire investor Eric Sprott's continued accumulation and short squeeze potential, and others warning about the company's current lack of production and revenue. This dynamic creates a highly contentious and volatile discussion as investors weigh speculative upside against fundamental concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enlivex Therapeutics (NASDAQ:ENLV) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded Enlivex Therapeutics from a "strong sell" rating to a "hold" rating in a report on Saturday...

Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Update

Enlivex Therapeutics Ltd. (NASDAQ:ENLV - Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totaling 603,238 shares...

Greenberg Traurig Advises Enlivex in $212M Private Placement

Greenberg Traurig Advises Enlivex in $212M Private Placement Greenberg Traurig Advises Enlivex in $212M Private Placement PR Newswire MIAMI, Dec. 4, 2025 Enlivex Becomes World's First Publicly Traded...

Small Cap Stocks To Add to Your Watchlist - November 24th

Direxion Daily GOOGL Bull 2X Shares, Spring Valley Acquisition, Direxion Daily TSLA Bear 1X Shares, Surmodics, and Enlivex Therapeutics are the five Small Cap stocks to watch today, according to...

Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors

Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors PR Newswire NESS ZIONA, Israel, Nov...

<ul class="summary-bullets"><li>Private investment in public equity (PIPE) raised $212 million through 212 million shares at $1 each.</li><li>Former Italian Prime Minister Matteo Renzi will join Enlivex’s board following the PIPE deal.</li><li>Enlivex aims to capture the growing prediction market sector, targeting competition with Polymarket and Kalshi.</li></ul>Shares of biotech company Enlivex Therapeutics (ENLV) jumped in pre-market trade on Monday after the company announced it would now be pivoting towards a crypto-backed treasury, with Rain Coin as its official token.&nbsp;The company also said that former Italian Prime Minister Matteo Renzi will be appointed to its board of directors.&nbsp;<a href="https://stocktwits.com/symbol/ENLV">ENLV’s stock</a> gained more than 70% in pre-market trade. On Stocktwits, retail sentiment around the company jumped to ‘extremely bullish’ from ‘neutral’ over the past day. Chatter increased to ‘extremely high’ from ‘high’ levels.&nbsp;Meanwhile,&nbsp;<a href="https://stocktwits.com/coins/rain-coin">RAIN’s price</a> nearly doubled in the last 24 hours. Retail sentiment around the token improved to ‘bullish’ from ‘neutral territory over the past day, accompanied by chatter at ‘high’ levels.&nbsp;<h2 class="st-heading-2">PIPE Deal To Fund RAIN Strategy</h2>Enlivex announced a private investment in public equity (PIPE) deal to raise $212 million by selling 212 million shares at $1 each, roughly 11.5% above last Friday’s closing price. The investment will be funded in both U.S. dollars and Tether’s USDT (USDT). Net proceeds are earmarked to implement “the first RAIN prediction markets token treasury strategy.”&nbsp;The company said it would also maintain focus on its core operations, including the late-stage clinical development of Allocetra, a therapy for osteoarthritis.<h2 class="st-heading-2">Targeting The Prediction Market Sector</h2>RAIN is a fully decentralized prediction and options protocol built on the Arbitrum network. With the protocol, Enlivex aims to capture the same growing market as firms like Polymarket and Kalshi, which have attracted billions in institutional investment.In October 2025, Polymarket secured a $2 billion investment from Intercontinental Exchange Inc. (ICE), the parent company of the New York Stock Exchange, which valued the company at around $8 billion. Meanwhile, Kalshi recently closed a $1 billion funding round in November 2025, which lifted its valuation to $11 billion.The PIPE transaction is expected to close on or before Tuesday.Read also:&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://cms.stocktwits.com/admin/content-manager/collection-types/api::article.article/16925">Bitcoin Holds $86,000 With Crypto Market Back Above $3 Trillion – XRP, Doge Gain Ahead Of Grayscale’s New ETF Launches</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Financial market volatility on digital interface with fluctuating trading data real-time stock market analysis and investment trends. (Stock picture/Getty Images)

ENLV Stock Surges After Pivot To Crypto-Backed Treasury, Names Former Italian PM To Board 

RAIN token price nearly doubled, with retail sentiment on Stocktwits trending ‘bullish’ and chatter at ‘high’ levels.

Equity

Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.

Enlivex Therapeutics Ltd

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$0.9805
Prev Close	$0.98
Open	$1.01
Dividend Yield	0.00%
50-Day Moving Average	$0.92
Beta	0.67
Avg. Volume	848,308.32
PE Ratio	-1.83

52-Week High	$2.10
52-Week Low	$0.66
Market Capitalization	$232.63M
EPS (Annual)	-$0.7319
Price to Book	1.36
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ENLV
Enlivex Therapeutics Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest ENLV News

ENLVEnlivex Therapeutics Ltd